Literature DB >> 23252007

Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial.

De-Gui Kong1, Yan-Fang Hou, Long-Le Ma, Dao-Kuo Yao, Le-Xin Wang.   

Abstract

OBJECTIVE: The efficacy of oral hydration in the prevention of contrast-induced nephropathy in patients undergoing elective coronary intervention is unclear.
METHODS: A total of 120 patients were randomly assigned to three groups. Group A (n = 40) received intravenous hydration before and after coronary angiography or angioplasty. Group B (n = 40) received oral tap water before and after the procedures, whereas group C (n = 40) received only postprocedural drinking water. Levels of serum creatinine and urea nitrogen were measured before, 12 hours after, 2 and 3 days after the coronary angiography or angioplasty.
RESULTS: : There was no statistically significant difference in the age, sex, baseline renal function and the volume of contrast medium used during the coronary procedures among the three groups (P > 0.05).There was no statistically significant difference in the mean serum creatinine or urea nitrogen among the three groups 12 hours, and 3 days after the coronary procedures ( P > 0.05).The incidence of contrast-induced nephropathy in group A, B and C was 5.0% (2/40), 7.5% (3/40) and 5.0% (2/40), respectively (P = 0.86). Renal function in the seven patients who experienced contrast-induced nephropathy recovered within a week following rehydration treatment.
CONCLUSIONS: Pre- and post-procedural oral hydration was as effective as intravenous rehydration in the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23252007     DOI: 10.1080/ac.67.5.2174131

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  17 in total

1.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

2.  Abdominal and pelvic CT: is positive enteric contrast still necessary? Results of a retrospective observational study.

Authors:  S Kammerer; A J Höink; J Wessling; H Heinzow; R Koch; C Schuelke; W Heindel; B Buerke
Journal:  Eur Radiol       Date:  2014-10-15       Impact factor: 5.315

3.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

Review 4.  [Contrast medium-induced acute kidney injury-Consensus paper of the working group "Heart and Kidney" of the German Cardiac Society and the German Society of Nephrology].

Authors:  J Latus; V Schwenger; G Schlieper; H Reinecke; J Hoyer; P B Persson; B A Remppis; F Mahfoud
Journal:  Internist (Berl)       Date:  2020-12-21       Impact factor: 0.743

Review 5.  Understanding and preventing contrast-induced acute kidney injury.

Authors:  Michael Fähling; Erdmann Seeliger; Andreas Patzak; Pontus B Persson
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

6.  Oral hydration as a safe prophylactic measure to prevent post-contrast acute kidney injury in oncologic patients with chronic kidney disease (IIIb) referred for contrast-enhanced computed tomography: subanalysis of the oncological group of the NICIR study.

Authors:  Carmen Sebastià; Alfredo Páez-Carpio; Elena Guillen; Blanca Paño; Joan Albert Arnaiz; Angel L M De Francisco; Carlos Nicolau; Laura Oleaga
Journal:  Support Care Cancer       Date:  2021-10-06       Impact factor: 3.359

7.  Early clinical outcomes of primary percutaneous coronary intervention in bharatpur, Nepal.

Authors:  Laxman Dubey; Rabindra Bhattacharya; Sogunuu Guruprasad; Gangapatnam Subramanyam
Journal:  Maedica (Buchar)       Date:  2013-06

8.  Percutaneous coronary intervention for chronic total occlusion improved prognosis in patients with renal insufficiency at high risk of contrast-induced nephropathy.

Authors:  Yong Liu; Yuanhui Liu; Hualong Li; Yingling Zhou; Wei Guo; Chongyang Duan; Shiqun Chen; Pingyan Chen; Ning Tan; Jiyan Chen
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

9.  Systematic oral hydration with water is similar to parenteral hydration for prevention of contrast-induced nephropathy: an updated meta-analysis of randomised clinical data.

Authors:  Shiv Kumar Agarwal; Sameh Mohareb; Achint Patel; Rabi Yacoub; James J DiNicolantonio; Ioannis Konstantinidis; Ambarish Pathak; Shailesh Fnu; Narender Annapureddy; Priya K Simoes; Sunil Kamat; Georges El-Hayek; Ravi Prasad; Damodar Kumbala; Rhanderson M Nascimento; John P Reilly; Girish N Nadkarni; Alexandre M Benjo
Journal:  Open Heart       Date:  2015-10-05

10.  Comparing common doses (double-dose vs usual-dose) of atorvastatin for preventing contrast-induced acute kidney injury and mortality after coronary angiography.

Authors:  Wei-Jie Bei; Shi-Qun Chen; Hua-Long Li; Deng-Xuan Wu; Chongyang Duan; Ping-Yan Chen; Ji-Yan Chen; Ning Tan; Nian-Jin Xie; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.